Outsourcing

Jan 01, 2017
BioPharm International
Robust venture capital investment gives CDMOs and CROs a positive outlook for 2017.
Dec 21, 2016
By BioPharm International Editors
AGC adds second biopharma contract manufacturer with acquisition of CMC Biologics.
Dec 01, 2016
BioPharm International
Biosimilars may be the key to CMO growth.
Nov 17, 2016
By BioPharm International Editors
Avecia is adding drug substance capacity at its Milford, MA manufacturing site.
Nov 01, 2016
BioPharm International
CMO executives are focusing on M&A activity, new business models, and fundraising limits.
Oct 24, 2016
By BioPharm International Editors
Catalent invests $34 million to add a 2 x 2000-L single-use bioreactor system and laboratory space in Madison, WI.
Oct 01, 2016
BioPharm International
This key bioprocessing segment is expecting continued growth.
Sep 01, 2016
BioPharm International
The strategies of a innovation-driven CMO may be different than a capacity-driven CMO.
Aug 15, 2016
By BioPharm International Editors
Agilent Technologies announces plans to build a new oligo manufacturing facility in Colorado that will double current capacity.
Aug 01, 2016
BioPharm International
CMOs are working hard to improve performance by investigating new technologies for filtration and purification.
native1_300x100
lorem ipsum